Daniel Becker | Head of Business Development INACTIVATE
KyooBe Tech GmbH

Day 1 - Tuesday 14th October @ 12:40

Start-Up Pitches

12:40 - Dr Benjamin Damien , CEO, Sagitta Biotech

12:45 - 'Comprehensive Immunopeptidomics Platform for Vaccine Development and Construct Validation' - Dr Elise Pepermans, CEO, ImmuneSpec

12:50 - Dr Vanessa Vankerckhoven, CEO, Idevax

12:55 - 'eFIT: A novel electron beam platform for Vaccine Manufacturing' - Daniel Becker, Head of Business Development, KyooBe Tech

13:00 - Bruno Vandelanotte, Head of EMEA Sales, Roncadelle Operations

13:05 - 'Unlocking Scalable Biomanufacturing for Advanced Therapies' - Dirk Hahneiser, General Manager, Cocoon Bioscience

13:10 - Markus Mandler, CEO & Founder, Tridem Bioscience

13:15 - Start-Up Pitch Feedback Panel

Benjamin DAMIEN, CEO, Sagitta Biotech

×

Benjamin DAMIEN / Start-Up Pitches

Benjamin DAMIEN, CEO,
Sagitta Biotech

Benjamin Damien is an innovative player and seasoned professional in the biotech industry, currently serving as the CEO of Sagitta Biotech.With over 22 years of experience in research, development, and strategic partnering within the global vaccine industry, Benjamin has a proven track record of...

CloseMore

Elise Pepermans, CEO & Co-Founder, ImmuneSpec BV

×

Elise Pepermans / Start-Up Pitches

Elise Pepermans, CEO,
ImmuneSpec BV

Elise Pepermans obtained her PhD in Biochemistry in the Pasteur Institut in Paris. During her post-doc in the Center for Proteomics (University of Antwerp/Flemish Institut for Technological Research) she developed an optimized workflow for advanced immunopeptidomics. Since March 2023, she is one of ...

CloseMore

Vanessa Vankerckhoven, CEO, IDEVAX

Daniel Becker, Head of Business Development INACTIVATE, KyooBe Tech GmbH

×

Daniel Becker / Start-Up Pitches

Daniel Becker, Head of Business Development INACTIVATE,
KyooBe Tech GmbH

Daniel Becker is responsible for Business Development of the eFIT platform at KyooBe Tech GmbH, focusing on innovative electron irradiation technologies for pathogen inactivation. With a background in biotechnology and process engineering, he has extensive experience in vaccine process...

CloseMore

Bruno Vandelanotte, Sales Manager EMEA, Roncadelle-Operations

Thom Frielink, Sr. Associate, Curie Capital BV

Darren Leneghan, Consultant, Life Sciences, Venture Valuation

×

Darren Leneghan / Start-Up Pitches

Darren Leneghan, Consultant, Life Sciences,
Venture Valuation

Darren holds a PhD in microbiology from Trinity College Dublin, where he also did his BA in microbiology. He spent a three year post-doc in the Jenner Institute at the University of Oxford developing vaccines against infectious diseases. He is an experienced team and project leader in both start-up ...

CloseMore

Dirk Hahneiser, CCO, Cocoon Bioscience

×

Dirk Hahneiser / Start-Up Pitches

Dirk Hahneiser, CCO,
Cocoon Bioscience

Dirk Hahneiser is a seasoned executive with over 25 years of experience in the medtech, biotechnology and pharmaceutical industries. As the Chief Commercial Officer at Cocoon Bioscience, Dirk is responsible for driving the company's commercial strategy and partnerships in the global enzyme...

CloseMore

Markus Mandler, Chief Executive Officer and Founder, Tridem Bioscience